NCT00610415已完成不适用
Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Quantification of the cancer stem cell population by flow cytometry
研究概览
简要总结
To see if a limited sampling of tumor tissue from human subjects is a feasible way to gather adequate tissue for cancer stem cell quantification.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with malignant tumors seen at the Stanford University Cancer Center. Eligible patients will have a diagnosis of squamous cell carcinoma (HNSCC) and will have been seen in the Stanford Head and Neck Oncology Program. A decision to undergo surgery at Stanford will have been made, prior to recruiting patients for the study, and prior to obtaining the samples during surgery. (Histological confirmation of the diagnosis need not be made prior to obtaining consent.)
- •A definitive resection of a malignant tumor is planned.
- •Surgeon judgment that the definitive procedure will not be compromised by including
- •Core needle biopsy
- •Cup forceps or punch biopsy of<4mm.
- •Informed consent documented prior to procedure
排除标准
- 未提供
结局指标
主要结局
Quantification of the cancer stem cell population by flow cytometry
时间窗: 1 month
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313Breast CancerNCT00949013SWOG Cancer Research Network1,600
已完成
不适用
Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin LymphomaLymphomaNCT01366157Children's Oncology Group23
招募中
不适用
Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse EventsHematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmNCT06640010Mayo Clinic30
招募中
不适用
Collection of Blood From Patients With CancerBreast CancerColon CancerProstate CancerLung CancerLiver CancerNCT00034216National Cancer Institute (NCI)1,750
Unknown
不适用
Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 TrialBreast CancerNCT01424865NSABP Foundation Inc1,874